Abstract
The TOPological Sub-Structural Molecular Design (TOPS-MODE) approach has been applied to the study of the affinity of A1 adenosine receptor of different N6-(substituted-phenylcarbamoyl) adenosine-5′-uronamides analogues. A model able to describe close to 84% of the variance in the values for binding experiments of 23 analogues of these compounds through multilinear regression analysis (MRA) was developed with the use of the mentioned approach. In contrast, no one of three different approaches, with the same number of variables, including the use of BCUT, randic molecular profiles, and geometrical descriptors was able to explain more than 75% of the variance in the mentioned property with the same number of descriptors.
In addition, the TOPS-MODE approach permitted us to find the contribution of different fragments to the biological property giving the model a straightforward structural interpretability.
Similar content being viewed by others
References
Baraldi, P. G., B. Cacciari, G. Spalluto, X. Ji, M. E. Olah, G. Stiles, S. Dionisotti, C. Zocchi, E. Ongini and K. A. Jacoboson (1996). Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. J. Med. Chem. 39, 802–806.
Belardinelli, L. (1993). Adenosine system in the heart. Drug Dev. Res. 28, 263–267.
Devillers, J. and R. L. Lipnick (1990). Practical applications of regression analysis in environmental QSAR studies, in Practical Applications of Quantitative Structure-Activity Relationships (QSAR) in Environmental Chemistry and Toxicology, K. Karcher and J. Devillers (Eds), Dordrecht: Kluwer, pp. 129–143.
Estrada, E. (1995). Edge adjacency relationship and a novel topological index related to molecular volume. J. Chem. Inf. Comput. Sci. 35, 31–33.
Estrada, E. (1996). Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications to the prediction of physical properties of alkanes. J. Chem. Inf. Comput. Sci. 36, 844–849.
Estrada, E. (1997). Spectral moments of the edge adjacency matrix in molecular graphs. 2. Molecules containing heteroatoms and QSAR applications. J. Chem. Inf. Comput. Sci. 37, 320–328.
Estrada, E. (1998a). Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles. J. Chem. Inf. Comput. Sci. 38, 23–27.
Estrada, E. (1998b). Modeling the diamagnetic susceptibilities of organic compounds by a substructural graph theoretical approach. J. Chem. Soc. Faraday Trans. 94, 1407–1411.
Estrada, E. and A. Peña (2000). In silico studies for the rational discovery of anticonvulsant compounds. Bioorg. Med. Chem. 8, 2755–2770.
Estrada, E. and E. Uriarte (2001). Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem. 8, 1573–1588.
Estrada, E., E. Uriarte, A. Montero, M. Tejeira, L. Santana and E. De Clercq (2000). J. Med. Chem 43, 1975–1985.
Garcia-Domenech, R. and J. V. Julian-Ortiz (1998). Antimicrobial activity characterization in a heterogeneous group of compounds. J. Chem. Inf. Comput. Sci. 38, 445–449.
González, M. P., H. González, R. Molina, M. A. Cabrera and R. Ramos (2003). TOPS MODE based QSARs derived from heterogeneous series of compounds. Application to the design of new herbicides. J. Chem. Inf. Comput. Sci. 43, 1192–1203.
González, D. H., E. Olazábal, N. Castañedo, S. I. Hernández, A. Morales, H. S. Serrano, J. González and R. Ramos de Armas (2002). J. Mol. Mod. 8, 237–245.
Gutierrez, Y. and E. Estrada (1997). TOSS-MODE (Topological Sub-structural Molecular Desing) for Windows, Version 4.0, Spain: Universidad de Santiago de Compostela.
Gutierrez, Y. and E. Estrada (2002). Modes Lab, version 1.0 b.
Hawkins, D. M. (2004). J. Chem. Inf. Comput. Sci. 44, 1–12.
Ivanciuc, O., T. Ivanciuc and A. T. Balaban (2000). Vertex and edge-weighted molecular graphs and derived structural descriptors, in Topological Indices and Related Descriptors, J. Devillers and A. T. Balaban (Eds), The Netherlands: Gordon & Breach, pp. 169–220.
Jacobson, K. A., P. J. van Galen and M. Williams (1992). Perspective adenosine receptors: pharmacology, structure-activity relationships and therapeutic potential. J. Med. Chem. 35, 407–422.
Libert, F., S. N. Schiffman, A. Lefort, M. Parmentier, C. Gerard, J. E. Dumont, J. Vanderhaeghen and G. Vassart (1991). The orphan receptor cDNA RDC7 encodes an A1 adenosine receptors. EMBO J. 10, 1677–1682.
Lipnick, R. L. (1991). Sci. Total Environ. 109, 131–153.
Lohse, M. J., K. N. Klotz, E. Diekmann, K. Friedrich and U. Schwabe (1988). Eur. J. Pharmacol. 156, 157–160.
Londos, C., D. M. Cooper and J. Wolff (1980). Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA. 77, 2551–2554.
Maenhaut, C., J. V. Sande, F. Liebert, M. Abramowicz, M. Parmentier, J. J. Vanderhaeghen, J. Dumont, G. Vassart and S. Schiffmann (1990). RDC8 codes for an adenosine A2 receptors with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173, 1169–1178.
Michael, J. S., E. Dewar, G. Zoebisch, F. Eamonn and J. P. Stewart (1985). J. Am. Chem. Soc. 107, 3902–3910.
Mishra, R. K., R. Garcia-Domenech and J. Galvez (2001). J. Chem. Inf. Comput. Sci. 41, 387–393.
Molina, E., H. D. González, M. P. González, E. Rodríguez and E. Uriarte (2004). Designing antibacterial compounds through a topological sub-structural approach. J. Chem. Inf. Comput. Sci. 44, 515–521.
Muller, C. E. (2000). Curr. Med. Chem. 7, 1269–1288.
Poulsen, S. A. and R. J. Quinn (1998). Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. 6, 619–641.
STATISTICA, version. 6.0 (2002). Statsoft, Inc.
Stehle, J. H., S. A. Rivkees, J. J. Lee, D. R. Weaver, J. D. Deeds and S. M. Reppert (1992). Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol. Endocrinol. 6, 384–393.
Stewar, J. J. P. (1990). MOPAC Manual, 6th edn., Colorado Springs, CO: Frank J. Seiler Research Laboratory, US Air Force Academy, p. 189.
Tao, P. L., M. H. Yen, W. S. Shyu and J. W. Chern (1993). Eur. J. Pharmacol. 243, 135–139.
Todeschini, R. and V. Consonni (2000). Handbook of Molecular Descriptors, Weinheim, Germany: Wiley-VCH.
Todeschini, R., V. Consonni and M. Pavan (2002). Dragon, Software version 2.1.
Topliss, J. G. and R. J. Costello (1972). J. Med. Chem. 15, 1066–1085.
Windsheif, U. (1996). Purinoreceptors: from history to recent progress. A review. J. Pharm. Pharmacol. 48, 993–1011.
Zhou, Q. Y., C. Y. Li, M. E. Olah, R. A. Johnson, G. L. Stiles and O. Civelli (1992). Molecular cloning and characterization of an adenosine receptor. The A3 adenosine receptor. Proc. Natl. Acad. Sci. USA. 89, 7432–7436.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
González, M.P., Moldes, M.d.C.T. QSAR study of N6-(substituted-phenylcarbamoyl) adenosine-5′-uronamides as agonist for A1 adenosine receptors. Bull. Math. Biol. 66, 907–920 (2004). https://doi.org/10.1016/j.bulm.2004.04.002
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/j.bulm.2004.04.002